ブラウザの設定でJava Scriptの使用を有効にしてご利用ください。
出典:Wikipedia
出典:『Wikipedia』 (2011/05/28 20:02 UTC 版)
MGAH22 is the experimental name of an anti-HER2/neu targeting monoclonal antibody developed by MacroGenics. Its mechanism of action is similar to the monoclonal antibody trastuzumab.
MGAH22